Fundraising Fox
Ventus Therapeutics
Waltham, US · Founded 2019 · Delaware corporation · 53 employees on LinkedIn · 11 known investors
Find your way into Ventus Therapeutics
Sign up to see every warm intro you have to Ventus Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ventus Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery. The company has advanced lead programs in Parkinson's disease and lupus through Phase 2 clinical trials.
Founders & leadership
Ventus Therapeutics was founded in 2019 by Judith Lieberman.
Board
Investors · 11
How we know: a16z's portfolio · press coverage · Not right? Tell us
How we know: GV (Google Ventures)'s portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: RA Capital's portfolio page · theglobeandmail.com · Not right? Tell us
How we know: Versant Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$186.8M disclosed across 3 rounds · 2019–2022
▶$70MraisedFeb 2022 · 13 investors · BiotechnologyRule 506(b)
- Steven JamesDirector
- Daniel KoerwerExecutive Officer
- Josh ResnickDirector
- Markus WarmuthDirector
- Michael CrackowerExecutive Officer
- Jane Pritchett HendersonDirector
- Jerel DavisDirector
- Marcelo BigalExecutive Officer, Director
- Dolca ThomasDirector
- Brendan Bulik-SullivanDirector
- John CassidyDirector
- Zachary McNealyExecutive Officer
- Offering amount
- $140M
- Amount sold
- $70M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$100MraisedApr 2021 · 17 investors · BiotechnologyRule 506(b)
- Daniel KoerwerExecutive Officer
- Josh ResnickDirector
- Jerel DavisDirector
- Steven JamesDirector
- Brendan Bulik-SullivanDirector
- Michael CrackowerExecutive Officer
- Zachary McNealyExecutive Officer
- Marcelo BigalExecutive Officer, Director
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$16.8MraisedMay 2020 · 4 investors · BiotechnologyRule 506(b)
- Jerel DavisDirector
- Daniel KoerwerExecutive Officer
- Hao WuDirector
- Zachary McNealyExecutive Officer
- Brendan Bulik-SullivanDirector
- Marcelo BigalExecutive Officer, Director
- Offering amount
- $60.1M
- Amount sold
- $16.8M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Ventus Therapeutics went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Ventus Therapeutics.
In the news
Frequently asked questions
- What does Ventus Therapeutics do?
- Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery. The company has advanced lead programs in Parkinson's disease and lupus through Phase 2 clinical trials.
- Who founded Ventus Therapeutics?
- Ventus Therapeutics was founded by Judith Lieberman in 2019.
- Who are Ventus Therapeutics's investors?
- Ventus Therapeutics's investors include Andreessen Horowitz, GV (Google Ventures), RA Capital, SoftBank Vision Fund, Versant Ventures, Alexandria, Biotechnology Value Fund, Casdin Capital and 2 more.
- How much funding has Ventus Therapeutics raised?
- Ventus Therapeutics has disclosed $186.8M raised across 3 rounds.
- Where is Ventus Therapeutics headquartered?
- Ventus Therapeutics is headquartered in Waltham, US.